2004
DOI: 10.1128/jvi.78.24.13637-13652.2004
|View full text |Cite
|
Sign up to set email alerts
|

Dissection of the Kaposi's Sarcoma-Associated Herpesvirus Gene Expression Program by Using the Viral DNA Replication Inhibitor Cidofovir

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
104
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 69 publications
(112 citation statements)
references
References 84 publications
7
104
1
Order By: Relevance
“…This kinetics of expression was closely related to EBV BGLF4, a homolog of vPK (15). Other investigators using microarray analysis, coupled with the use of an inhibitor of viral DNA synthesis, also showed that the vPK gene was expressed early in the viral lytic cycle (31). In K-Rta-inducible BCBL-1 cells, the 4.2-kb transcript, encoding ORF34 to ORF38, was sensitive to PAA; this finding differs from an earlier report (18).…”
Section: Discussioncontrasting
confidence: 56%
See 3 more Smart Citations
“…This kinetics of expression was closely related to EBV BGLF4, a homolog of vPK (15). Other investigators using microarray analysis, coupled with the use of an inhibitor of viral DNA synthesis, also showed that the vPK gene was expressed early in the viral lytic cycle (31). In K-Rta-inducible BCBL-1 cells, the 4.2-kb transcript, encoding ORF34 to ORF38, was sensitive to PAA; this finding differs from an earlier report (18).…”
Section: Discussioncontrasting
confidence: 56%
“…In previous reports, the vPK gene was shown to be expressed as either an early or a late gene during lytic replication, depending on the conditions used to reactivate virus in latently infected B-lymphoid tumor cells (22,31,38,39). Because the mode of action of the inducers (e.g., phorbol ester or butyrate) is complex and the fraction of cells affected is relatively small, we chose to measure the expression kinetics of vPK by K-Rta-mediated reactivation.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Nucleoside analogs that selectively inhibit viral DNA replication are the first line anti-herpesvirus drugs. Originally developed to treat herpes simplex virus infection, they also inhibit KSHV in vitro 60,[64][65][66] and have displayed activity against KSHV-associated disease based on reductions in viral oropharyngeal shedding 67,68 and clinical relief of MCD symptoms. 34,35 At the outset, we considered three alternatives: (1) ganciclovir and the immunotoxin might display additive anti-KSHV activities; (2) they might detected on a small subpopulation of induced cells; this pattern was not observed on uninduced cells (data not shown).…”
Section: Resultsmentioning
confidence: 99%